New treatment option for rare, life-altering pediatric brain tumors Less than 10% of new medicine approvals over the past five years have focused on pediatric diseases; Ojemda ® (tovorafenib) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results